Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

ussia and Iran have obtained voter registration information, and that Iran has used that information to send threatening messages to voters." ABC's Pierre Thomas reported on the "new details about alleged covert efforts by Russia and Iran to weaponize illegally obtained information about American voters." FB

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

ussia and Iran have obtained voter registration information, and that Iran has used that information to send threatening messages to voters." ABC's Pierre Thomas reported on the "new details about alleged covert efforts by Russia and Iran to weaponize illegally obtained information about American voters." FBI

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

Russia and Iran have obtained voter registration information, and that Iran has used that information to send threatening messages to voters." ABC's Pierre Thomas reported on the "new details about alleged covert efforts by Russia and Iran to weaponize illegally obtained information about American voters." FB